Back
BioLife Solutions 10K Form
Sell
49
BLFS
BioLife Solutions
Last Price:
$23.91
Seasonality Move:
11.06%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-10 | 10Q | BLFS/BioLife Solutions Quarterly |
| 2023-11-09 | 10Q | BLFS/BioLife Solutions Quarterly |
| 2023-08-09 | 10Q | BLFS/BioLife Solutions Quarterly |
| 2023-05-11 | 10Q | BLFS/BioLife Solutions Quarterly |
| 2022-11-09 | 10Q | BLFS/BioLife Solutions Quarterly |
| 2022-08-09 | 10Q | BLFS/BioLife Solutions Quarterly |
Receive BLFS News And Ratings
See the #1 stock for the next 7 days that we like better than BLFS
BLFS Financial Statistics
Sales & Book Value
| Annual Sales: | $82.3M |
|---|---|
| Cash Flow: | $1.6M |
| Price / Cash Flow: | 95.93 |
| Annual Sales: | $7.42 |
| Price / Book: | 3.14 |
Profitability
| EPS (TTM): | -0.24000 |
|---|---|
| Net Income (TTM): | $-10.4M |
| Gross Margin: | $53.7M |
| Return on Equity: | -3.1% |
| Return on Assets: | -2.67% |
BioLife Solutions Earnings Forecast
Key BioLife Solutions Financial Ratios
-
The Gross Profit Margin over the past 36 years for BLFS is 65.25%.
-
The Selling, General & Administrative Expenses for BLFS have been equal to 60.97% of Gross Profit Margin.
-
The Research & Development expenses have been 9.62% of Revenue.
-
The Net Earning history of BLFS is -24.54% of Total Revenues.
-
Per Share Earnings over the last 36 years have been positive in 16 years.
BioLife Solutions Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | BLFS |
| CUSIP: | 09062W |
| Website: | biolifesolutions.com |
Debt
| Debt-to-Equity Ratio: | 0.04 |
|---|---|
| Current Ratio: | 4.73 |
| Quick Ratio: | 3.53 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 137 |
BLFS Technical Analysis vs Fundamental Analysis
Sell
49
BioLife Solutions (BLFS)
is a Sell
Is BioLife Solutions a Buy or a Sell?
-
BioLife Solutions stock is rated a SellThe current BioLife Solutions [BLFS] share price is $23.29. The Score for BLFS is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.